Zobrazeno 1 - 4
of 4
pro vyhledávání: '"S. Oh"'
Publikováno v:
Cytotherapy. 22:S97
Background & Aim Porous polycaprolactone (PCL)-based microcarriers (MC) can be used for large-scale production of human mesenchymal stromal cells (MSC) in stirred bioreactors. These biodegradable MC can deliver MSC, which improved bone healing in a r
Publikováno v:
Cytotherapy. 22:S88
Background & Aim Mesenchymal stem cells (MSCs) have been considered as a potential tool in regenerative medicine for their great multipotency characteristics into various cell types. In past years, our group have been studying tonsil-derived MSCs (TM
Autor:
J. Sivalingam, S. Oh
Publikováno v:
Cytotherapy. 21:S18
Background & Aim Universal red blood cells (RBCs) derived from differentiation of O-negative (neg) human induced pluripotent stem cells (hiPSCs) can potentially supplement the emergency transfusion needs of the healthcare industry. Given that each un
Publikováno v:
Cytotherapy. 18:S18